Skip to main content
Top
Published in: Infection 3/2014

01-06-2014 | Case Report

Antineutrophil cytoplasmic antibody-associated vasculitis associated with Epstein–Barr virus infection: a case report and review of the literature

Authors: P. Xu, S. Lin, L. Wei, W. Shang

Published in: Infection | Issue 3/2014

Login to get access

Abstract

A 16-year-old female with fever was admitted to our hospital. On admission, her serum IgM antibody against Epstein–Barr virus (EBV) was positive. Then, the disease aggravated and acute kidney injury occurred gradually. Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) was confirmed by serum test and kidney biopsy. The patient was treated with oral methylprednisolone. Along with the disappearance of the IgM anti-EBV antibody, the AAV also relieved without relapse during follow-up for half a year. Although a previous study indicated that there was a high positive rate of ANCA in the sera positive for IgM antibodies to EBV and EBV infection might trigger the relapse of AAV, this is the first case of incipient AAV associated with acute EBV infection. One possible explanation might be that EBV infection stimulated the production of ANCA.
Literature
1.
go back to reference Toussirot E, Roudier J. Epstein–Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22:883–96.PubMedCrossRef Toussirot E, Roudier J. Epstein–Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22:883–96.PubMedCrossRef
2.
go back to reference Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628–36.PubMedCrossRef Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628–36.PubMedCrossRef
3.
go back to reference Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance. Arthritis Rheum. 1995;38:633–7.PubMedCrossRef Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance. Arthritis Rheum. 1995;38:633–7.PubMedCrossRef
4.
go back to reference Sihvonen S, Korpela M, Mustila A, Mustonen J. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005;32:2089–94.PubMed Sihvonen S, Korpela M, Mustila A, Mustonen J. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis. J Rheumatol. 2005;32:2089–94.PubMed
5.
go back to reference Spadaro M, Amendolea MA, Mazzucconi MG, et al. Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler. 1999;5:121–5.PubMedCrossRef Spadaro M, Amendolea MA, Mazzucconi MG, et al. Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler. 1999;5:121–5.PubMedCrossRef
6.
go back to reference Cil T, Altintas A, Isikdogan A, Batun S. Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin’s and non-Hodgkin lymphoma: a single center experience. Int J Hematol. 2009;90:52–7.PubMedCrossRef Cil T, Altintas A, Isikdogan A, Batun S. Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin’s and non-Hodgkin lymphoma: a single center experience. Int J Hematol. 2009;90:52–7.PubMedCrossRef
7.
go back to reference Reese GE, Constantinides VA, Simillis C, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol. 2006;101:2410–22.PubMedCrossRef Reese GE, Constantinides VA, Simillis C, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol. 2006;101:2410–22.PubMedCrossRef
8.
go back to reference Nishiya K, Chikazawa H, Hashimoto K, Miyawaki S. Antineutrophil cytoplasmic antibody in patients with primary Sjögren’s syndrome. Clin Rheumatol. 1999;18:268–71.PubMedCrossRef Nishiya K, Chikazawa H, Hashimoto K, Miyawaki S. Antineutrophil cytoplasmic antibody in patients with primary Sjögren’s syndrome. Clin Rheumatol. 1999;18:268–71.PubMedCrossRef
9.
go back to reference Ruffatti A, Sinico RA, Radice A, et al. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol. 2002;29:918–23.PubMed Ruffatti A, Sinico RA, Radice A, et al. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol. 2002;29:918–23.PubMed
10.
go back to reference De Riva V, Celadin M, Pittoni M, Plebani M, Angeli P. What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease? Liver Int. 2009;29:865–70.PubMedCrossRef De Riva V, Celadin M, Pittoni M, Plebani M, Angeli P. What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease? Liver Int. 2009;29:865–70.PubMedCrossRef
11.
go back to reference Pietravalle P, Monteleone G, Morano S, et al. Antineutrophil cytoplasmic antibodies are present in long standing type 1 diabetics but do not correlate with selective proteinuria. J Autoimmun. 1996;9:113–7.PubMedCrossRef Pietravalle P, Monteleone G, Morano S, et al. Antineutrophil cytoplasmic antibodies are present in long standing type 1 diabetics but do not correlate with selective proteinuria. J Autoimmun. 1996;9:113–7.PubMedCrossRef
12.
go back to reference Lidar M, Lipschitz N, Langevitz P, et al. Infectious serologies and autoantibodies in Wegener’s granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Ann N Y Acad Sci. 2009;1173:649–57.PubMedCrossRef Lidar M, Lipschitz N, Langevitz P, et al. Infectious serologies and autoantibodies in Wegener’s granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Ann N Y Acad Sci. 2009;1173:649–57.PubMedCrossRef
13.
go back to reference Daikeler T, Erley C, Mohren M, et al. Fever and increasing cANCA titre after kidney and autologous stem cell transplantation for Wegener’s granulomatosis. Ann Rheum Dis. 2005;64:646–7.PubMedCentralPubMedCrossRef Daikeler T, Erley C, Mohren M, et al. Fever and increasing cANCA titre after kidney and autologous stem cell transplantation for Wegener’s granulomatosis. Ann Rheum Dis. 2005;64:646–7.PubMedCentralPubMedCrossRef
14.
go back to reference Schned AR, Ornvold K, Tsongalis GJ, Chobanian MC. Fatal relapse of ANCA-associated glomerulonephritis triggered by successive Epstein–Barr and varicella zoster virus infections. Am J Kidney Dis. 2006;47:915–22.PubMedCrossRef Schned AR, Ornvold K, Tsongalis GJ, Chobanian MC. Fatal relapse of ANCA-associated glomerulonephritis triggered by successive Epstein–Barr and varicella zoster virus infections. Am J Kidney Dis. 2006;47:915–22.PubMedCrossRef
15.
go back to reference Anders HJ, Vielhauer V, Eis V, et al. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 2004;18:534–6.PubMed Anders HJ, Vielhauer V, Eis V, et al. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 2004;18:534–6.PubMed
16.
go back to reference Allam R, Pawar RD, Kulkarni OP, et al. Viral 5′-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses. Eur J Immunol. 2008;38:3487–98.PubMedCrossRef Allam R, Pawar RD, Kulkarni OP, et al. Viral 5′-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses. Eur J Immunol. 2008;38:3487–98.PubMedCrossRef
17.
go back to reference Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416:603–7.PubMedCrossRef Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416:603–7.PubMedCrossRef
18.
go back to reference Anders HJ, Lichtnekert J, Allam R. Interferon-alpha and -beta in kidney inflammation. Kidney Int. 2010;77:848–54.PubMedCrossRef Anders HJ, Lichtnekert J, Allam R. Interferon-alpha and -beta in kidney inflammation. Kidney Int. 2010;77:848–54.PubMedCrossRef
19.
go back to reference Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol. 2005;23:307–36.PubMedCrossRef Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol. 2005;23:307–36.PubMedCrossRef
20.
go back to reference Xu PC, Cui Z, Chen M, Hellmark T, Zhao MH. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis. Rheumatology (Oxford). 2011;50:1236–43.CrossRef Xu PC, Cui Z, Chen M, Hellmark T, Zhao MH. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis. Rheumatology (Oxford). 2011;50:1236–43.CrossRef
Metadata
Title
Antineutrophil cytoplasmic antibody-associated vasculitis associated with Epstein–Barr virus infection: a case report and review of the literature
Authors
P. Xu
S. Lin
L. Wei
W. Shang
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0606-4

Other articles of this Issue 3/2014

Infection 3/2014 Go to the issue